The honest evidence tier for sermorelin is therefore human, but older and narrow, with the further complication that the material available today is not the FDA-approved product those older studies used
"ASCO Annual Meeting Proceedings Part I
ScienceDirect , World Journal of Gastroenterology , vol
For patients seeking additional peptide synergy, PlexusDx provides Compounded Tirzepatide Injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan)a dual GLP-1/GIP receptor agonist that may produce superior weight loss compared to semaglutide alone, based on the SURMOUNT clinical trials
Patients are sometimes surprised that we do not immediately increase their dose when they feel hungry early on
They represent a significant, sometimes dramatic shift, in how we approach the complex interplay of hormones regulating body weight and glucose homeostasis